Skip to Content


Enrollment and Retention of Participants in NIH-Funded Clinical Trials-Notice of Meeting

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble


The National Institutes of Health (NIH) will hold a teleconference with interested stakeholders to gather perspectives on issues related to the enrollment and retention of research participants in NIH-funded clinical trials. The stakeholder input will inform the planning of an NIH workshop on this topic that will be scheduled this summer.


May 16, 2014, from 3:00 p.m.-4:30 p.m., ET.


The meeting will be held by teleconference. A teleconference agenda and logistical information will be posted in advance of the teleconference at the following Web site:​.

Start Further Info


Valery Gordon, Ph.D., Acting Director, Clinical Research Program, Office of Science Policy, NIH; email:; telephone: 301-496-9838.

End Further Info End Preamble Start Supplemental Information


The stakeholder teleconference meeting will enable the NIH to gather perspectives from interested parties on issues related to the clinical trial recruitment and retention that could be explored in the workshop. For the purposes of planning the workshop agenda, the NIH is particularly interested in the perspectives of public foundations and other organizations currently working in this area. The topics that are to be explored in the workshop include the following: Outside coordination with NIH-supported clinical trials and public foundations; models to identify and support trial participants; potential public-private partnerships; methods to increase participation, including underrepresented and uninsured populations; and potential measures to track and monitor participation in NIH-supported clinical trials.

Start Signature

Dated: April 26, 2014.

Lawrence A. Tabak,

Principal Deputy Director, NIH.

End Signature End Supplemental Information

[FR Doc. 2014-10154 Filed 5-2-14; 8:45 am]